A 28-year-old woman with a history of asthma presents to the emergency department with acute peritonitis secondary to a perforated appendix. She is conscious, alert, and hemodynamically stable (BP 128/76 mmHg, HR 96/min, RR 24/min). Her last meal was 3 hours ago. During RSI, which of the following neuromuscular blocking agents should be AVOIDED in this patient, and why?

Explanation

## Neuromuscular Blocker Selection in Asthmatic Patient Undergoing RSI **Key Point:** In a patient with asthma undergoing RSI, **atracurium must be avoided** because it causes histamine release from mast cells, which can trigger acute bronchospasm — potentially catastrophic in an asthmatic. ### Why Atracurium Is Contraindicated Atracurium's mechanism of histamine release: 1. **Direct mast cell degranulation** — releases histamine and tryptase 2. **Dose-dependent effect** — higher doses = greater histamine release 3. **Clinical consequence in asthma** — histamine → H1/H2 receptor activation → bronchoconstriction, hypotension, tachycardia 4. **Timing** — histamine release occurs within seconds of IV administration **Clinical Pearl:** In asthmatic patients, the combination of: - Acute peritonitis (inflammatory state) - Histamine release from atracurium - Hyperreactive airway ...creates a **"perfect storm"** for intraoperative bronchospasm, which is difficult to manage during anesthesia. ### Neuromuscular Blocker Comparison in Asthma | Agent | Histamine Release | Asthma Safety | Onset | Duration | Use in RSI | |-------|-------------------|---------------|-------|----------|------------| | **Succinylcholine** | Mild (dose-dependent) | Acceptable | 30–40 sec | 5–10 min | **PREFERRED** | | **Atracurium** | **MARKED** | **CONTRAINDICATED** | 30–45 sec | 30–45 min | **AVOID** | | **Cisatracurium** | Minimal | Excellent | 40–60 sec | 40–60 min | **EXCELLENT** | | **Vecuronium** | None | Excellent | 30–40 sec | 30–40 min | **EXCELLENT** | **High-Yield:** Cisatracurium (a stereoisomer of atracurium) undergoes **Hofmann elimination** (independent of organ function) and does **NOT release histamine** — making it the ideal non-depolarizing agent in asthmatic patients. **Mnemonic — Histamine-Releasing NMBs:** - **A**tracurium = **A**void in asthma (histamine release) - **M**ivacurium = **M**inor histamine release - **C**isatracurium = **C**lean (no histamine) ### RSI Protocol in This Asthmatic Patient ```mermaid flowchart TD A[28F, asthma<br/>Perforated appendix<br/>Hemodynamically stable]:::outcome --> B[RSI indicated?]:::decision B -->|Yes| C[Preoxygenation 3 min]:::action C --> D[Induction: Etomidate or Propofol]:::action D --> E{Choose NMB}:::decision E -->|Avoid| F[Atracurium<br/>Histamine release]:::urgent E -->|Preferred| G[Succinylcholine 1.5 mg/kg]:::action E -->|Excellent alternative| H[Cisatracurium 0.15 mg/kg]:::action G --> I[Intubate]:::action H --> I I --> J[Proceed to surgery]:::outcome F --> K[Risk of bronchospasm]:::urgent ``` **Warning:** Atracurium is absolutely contraindicated in asthmatic patients. Even "small doses" can trigger histamine release and bronchospasm. If atracurium is inadvertently given, be prepared for acute bronchospasm management (IV salbutamol, IV steroids, increased minute ventilation). ### Why Other Options Are Wrong - **Succinylcholine** causes mild histamine release (dose-dependent), but it is **acceptable** in asthma and is the fastest-onset agent for RSI. The benefit of rapid paralysis outweighs the minimal histamine risk. - **Vecuronium** and **cisatracurium** do NOT release histamine and are both safe — but the question asks what should be AVOIDED. **Clinical Pearl:** In this hemodynamically stable asthmatic, succinylcholine is the preferred NMB for RSI (fastest onset, minimal histamine). If there were contraindications to succinylcholine (e.g., burns, crush injury, hyperkalemia), cisatracurium would be the non-depolarizing agent of choice.